Search Results

Displaying: 25 / 100 / 200 results

Ordered by: Date (newest first) / Date (oldest first)

Co-operation keeps contracts coming

11 July 2014 Business

Clubbing together gives contract research organisations more power to win new business in an evolving market

First of a new breed of anticancer antibodies approved in Japan

8 July 2014 Business

Ono claims Opdivo is the first anti-PD1 treatment in the world

ADM to buy food ingredients specialist Wild Flavors

8 July 2014 Business

€2.3bn deal gets ADM into rapidly-growing area of naturally-sourced flavourings

Show the way but leave no trace

3 July 2014 Organic Matter

Karl Collins examines a stealthy strategy for directed C–H activation

Ineos takes full control of Styrolution

3 July 2014 Business

€1.1bn deal sees BASF complete its planned exit from styrenics joint venture

Genentech to buy breast cancer specialist Seragon

2 July 2014 Business

$1.7bn deal for hormone receptor-destroying drug pipeline

PPG to buy Mexican paints firm Comex

1 July 2014 Business

$2.3bn deal expands US firm’s footprint in Central America

Bayer to close polycarbonate plant and cut 90 jobs

1 July 2014 Business

Firm has already shut Chinese plant, and will also sell off businesses in Australia and New Zealand

Affymax folds after drug withdrawal

30 June 2014 Business

Unexplained allergic reactions to anaemia drug prompt firm to dissolve

Inhaled insulin approved in US

30 June 2014 Business

European committee recommends approval for generic long-acting insulin

Biotech bounced back in 2013, says report

24 June 2014 Business

R&D investment increasing, but industry needs to use its cash more wisely

Shire fends off AbbVie takeover bid

23 June 2014 Business

Board says deal undervalues the company and its growth potential

Novo Nordisk to create 6000 jobs by 2022

16 June 2014 Business

Half of the new Danish employees will be in R&D roles

Medtronic to buy Covidien for $43bn

16 June 2014 Business

Tax inversion deal continues consolidation theme among medical device makers

Merck & Co bolsters hepatitis C pipeline with Idenix acquisition

12 June 2014 Business

Early-stage drugs complement Merck’s own developmental portfolio

Data sharing helps firms reduce Reach animal testing

6 June 2014 Business

Alternative in vitro methods slowly gaining traction for some tests

Generics giants jostle over pain drug

4 June 2014 Business

Mylan and Actavis contest Teva’s generic celecoxib exclusivity

Drug companies rapped for anticompetitive behaviour

3 June 2014 Business

Italian authorities demand €1.2 billion in damages from Roche, Novartis and Pfizer

Nano risk register not necessary, says BASF

2 June 2014 Business

Reach covers the relevant information, and a register risks attracting unwarranted stigma

Boehringer to settle blood thinner drug suits for $650m

29 May 2014 Business

Company confident in drug safety but says court cases are too risky

Time called on Pfizer–AstraZeneca deal

28 May 2014 Business

Pfizer could make a fresh approach after six months under City takeover rules

Mitsui continues reinvention efforts with two deals

22 May 2014 Business

Japanese firm drops organic acids in favour of lens materials

Novartis enhances its focus with eyecare deal

21 May 2014 Business

Swiss firm buys rights to wet AMD drug from Ophthotech for up to $1bn

Abbott to buy Chile’s CFR for $3bn

21 May 2014 Business

Generics deal reinforces firm’s Latin American presence

AstraZeneca refuses Pfizer’s ‘final’ offer

19 May 2014 Business

Pfizer pledges not to make hostile bid direct to shareholders